Review



injection  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress injection
    Injection, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41918143-109-8-2
    Average 94 stars, based on 21 article reviews
    injection - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Blocking IL-6 down-regulates PD-L1 expression and mitigates pulmonary fibrosis by inhibiting the STAT3 signaling pathway.
    Article Snippet: Pulmonary fibrosis is a fatal lung disease.. Owing to its unknown pathogenesis, treatment options are limited.. Interleukin (IL)-6, a multifunctional cytokine, is overexpressed in pulmonary fibrosis and may contribute to its development through multiple pathways, mainly the signal transduction and transcriptional activator 3 (STAT3) signaling pathway.

    Control:

    Article Title: Inhibition of glutamine metabolism blocks tumor growth and sensitizes ccRCC to immune checkpoint blockade.
    Article Snippet: .. Drugs The following drugs were used in this study: 6-diazo-5-oxo-L- norleucine (DON) (Cat#HY-108357), Sirpiglenastat (DRP-104) (Cat#HY-132832), Telaglenastat (CB-839) (Cat#HY-12248), Gefitinib (Cat#HY-50895), U0126 (MEK1 and MEK2 inhibitor, AR TIC LE IN PR ES S Cat#HY-12031), SP600125 (JNK1/2/3 inhibitor, Cat#HY-12041), LGlutathione reduced (Cat#HY-D0187), anti-Mouse PD-L1/B7-H1 antibody (10F.9G2) (Cat#HY-P99145), rat lgG2b kappa isotype control (Cat#HY-P990682), Tween 80 (Cat#HY-Y1891), and hydroxypropyl-β-cyclodextrin (HP-β-CD) (Cat#HY-101103), all purchased from MedChemExpress (USA). .. N-acetyl-l-cysteine (NAC) (Cat#A9165) was purchased from Sigma (USA).



    Similar Products

    injection  (MedChemExpress)
    94
    MedChemExpress injection
    Injection, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41918143-109-8-2
    Average 94 stars, based on 1 article reviews
    injection - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti pd l1 antibody  (MedChemExpress)
    94
    MedChemExpress anti pd l1 antibody
    Anti Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41740833-88-1-3
    Average 94 stars, based on 1 article reviews
    anti pd l1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti-mouse pd-l1/b7-h1 antibody  (MedChemExpress)
    94
    MedChemExpress anti-mouse pd-l1/b7-h1 antibody
    Anti Mouse Pd L1/B7 H1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/custom%40hy-p99145%4041740833
    Average 94 stars, based on 1 article reviews
    anti-mouse pd-l1/b7-h1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti mouse pd l1 b7 h1 antibody  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1 b7 h1 antibody
    Anti Mouse Pd L1 B7 H1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41580750-79-41-62
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 b7 h1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    p99145  (MedChemExpress)
    94
    MedChemExpress p99145
    P99145, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41580750-79-45-62
    Average 94 stars, based on 1 article reviews
    p99145 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    antipd l1 antibody  (MedChemExpress)
    94
    MedChemExpress antipd l1 antibody
    Antipd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1%2FB7-H1+Antibody/pm41370882-365-1-5
    Average 94 stars, based on 1 article reviews
    antipd l1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti mouse pd l1 antibody  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1 antibody
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Anti Mouse Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1+Antibody/pmc12712317-55-2-13
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti mouse pd l1  (MedChemExpress)
    94
    MedChemExpress anti mouse pd l1
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Anti Mouse Pd L1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1+Antibody/pm41418943-251-38-67
    Average 94 stars, based on 1 article reviews
    anti mouse pd l1 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    antimouse pd l1 antibody  (MedChemExpress)
    94
    MedChemExpress antimouse pd l1 antibody
    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), <t>anti-PD-L1</t> (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.
    Antimouse Pd L1 Antibody, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p99145/Anti-Mouse+PD-L1+Antibody/pm41406067-43-2-13
    Average 94 stars, based on 1 article reviews
    antimouse pd l1 antibody - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Combining Radiation and anti-PD-L1 Enhances the Antitumor Activity in Colorectal Cancer via IFN-γ-Dependent Activation of STAT1

    doi: 10.1177/15330338251406931

    Figure Lengend Snippet: In vivo treatment schedule and therapeutic outcomes. (A) Experimental timeline for control, radiotherapy (IR), anti-PD-L1 (ICI), and combination groups. (B) Positioning of tumor-bearing mice for 6 MV x-ray irradiation. (C) Representative image of tumor harvesting on day 7. (D) Tumor-growth curves (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. ∗, ∗∗, ∗∗∗, or ∗∗∗∗ represent p-values <0.05, < 0.01, < 0.001, and <0.0001, respectively. X-axis: Number of days, corresponding to the treatment timeline, with the first day being the first day of treatment. Y-axis: Tumor volume growth, measured as the difference between the tumor volume on the day of measurement and the tumor volume before treatment (first day). (E) Body-weight changes over the study period (mean ± SD; n = 4 per group); statistical methods: one-way ANOVA. X-axis: Number of days. Y-axis: Mouse weight, measured as mouse weight on the day of measurement.

    Article Snippet: Therapeutic agents: anti-mouse PD-L1 antibody (clone 10F.9G2), recombinant mouse IFN-γ and Itacitinib (both MedChemExpress).

    Techniques: In Vivo, Control, Irradiation